Caffeine-8-hydrazones as novel cytostatics for the treatment of oncologic diseases

摘要

The present invention relates to caffeine-8-hydrazones of the general formula I, having substituted 2-hydroxyaryl, pyridine or pyrazine group. These substances exhibit cytostatic activity and can be therefore used for the preparation of therapeutics for the treatment of oncologic diseases.